Skip Navigation



Home » Drug Information » FDA Approved Drugs » 1998
Medical Areas: Immunology | Ophthalmology | Pediatrics/Neonatology | Infections and Infectious Diseases

View By:YearCompanyConditionsTherapeutic AreasDrug Names


The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: King Pharmaceuticals
Approval Status: Approved February 1998
Treatment Area: inflammation of the cornea due to herpes simplex virus

General Information

Viroptic Oththalmic Solution (trifluridine) 1% has been approved for use in children (ages 6+) as a treatment for inflammation of the cornea caused by the herpes simplex virus. The antiviral agent was previously approved for use in adults.